亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台，协助业界发掘知识产权贸易商机，并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权，或是制造商需要购买技术以提高操作效能，又或是知识产权配套服务供应商，你将会从本网站发掘到有用的知识产权贸易资讯。

返回搜索结果

Drug Discovery Screening for Cyclophilin D Antagonists in Alzheimer's Disease

总结: Lead Inventors: Shi Du Yan, M.D.Problem or Unmet Need:Alzheimer's disease is the leading cause of neurodegenerative dementia, affecting over 35 million persons worldwide. The costs of care for this disease are enormous with direct healthcare costs estimated at $25 billion as well as indirect caregiver costs at $36.5 billion due to lost productivity. Unfortunately, few therapeutic options are available for treatment and prevention of this debilitating disease. New molecular targets for prevention and reversal of the dementia caused by Alzheimer's are needed for effective treatment. This technology demonstrates a novel drug screening assay in which compounds that activate the cyclophilin D pathway can be identified for the treatment of Alzheimer's disease. The authors of this technology have demonstrated that blockade of the cypophilin D protein protects against impaired memory and learning in animal models of Alzheimer's disease. Small molecules and/or biologic antibodies inhibiting cyclophilin D thus can be used for therapeutic treatment and prevention of Alzheimer's disease progression. The technology details methods for detection of compound affinity to the cyclophilin D complex as well as functional assays to determine the physiologic inhibition of cyclophilin cellular activity.

技术优势: Novel molecular target Structural and functional screening assays Animal models available

技术应用: Drug discovery for Alzheimer's disease o Small molecule o Antibodies o Peptides o siRNA

详细技术说明: This technology demonstrates a novel drug screening assay in which compounds that activate the cyclophilin D pathway can be identified for the treatment of Alzheimer's disease. The authors of this technology have demonstrated that blockade of t...

*Inquiry: Jerry Kokoshka Columbia Technology Ventures Tel: (212) 854-8444 Email: TechTransfer@columbia.edu

*Publications: Du et al. Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease. Nature Medicine. 2008 Oct;14(10):1097-105.

欲了解更多信息，请点击这里